Pages that link to "Q35798976"

The following pages link to Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study (Q35798976):

Displaying 46 items.

• Strategies for early detection of resectable pancreatic cancer (Q24564006) (← links)
• Molecular detection of pancreatic neoplasia: Current status and future promise (Q26777379) (← links)
• Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges (Q26824034) (← links)
• Applications of targeted proteomics in systems biology and translational medicine (Q26852271) (← links)
• Advances in targeted proteomics and applications to biomedical research (Q28066912) (← links)
• Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. (Q30368922) (← links)
• Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers (Q33703750) (← links)
• PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species (Q34117442) (← links)
• Bacterial protein signals are associated with Crohn's disease (Q34237245) (← links)
• Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics (Q34292436) (← links)
• Mapping O-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles. (Q34555445) (← links)
• N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications (Q34585592) (← links)
• Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine (Q34657038) (← links)
• Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition (Q35847101) (← links)
• Proteomics analysis of bodily fluids in pancreatic cancer (Q35920900) (← links)
• Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics (Q36118351) (← links)
• Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. (Q36321648) (← links)
• Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues (Q36745621) (← links)
• Both targeted mass spectrometry and flow sorting analysis methods detected the decreased serum apolipoprotein E level in Alzheimer's disease patients (Q37563867) (← links)
• Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry (Q37618631) (← links)
• Metabolism addiction in pancreatic cancer (Q37620679) (← links)
• Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach (Q37623655) (← links)
• A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research. (Q37651691) (← links)
• Plasma Gelsolin Induced Glomerular Fibrosis via the TGF-β1/Smads Signal Transduction Pathway in IgA Nephropathy (Q37690933) (← links)
• MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum (Q38183147) (← links)
• Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays (Q38203040) (← links)
• Biomarkers for early diagnosis of pancreatic cancer (Q38265405) (← links)
• Premetastatic niche formation in the liver: emerging mechanisms and mouse models (Q38591967) (← links)
• Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS. (Q38703928) (← links)
• Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives (Q38753775) (← links)
• Clinical applications of MS-based protein quantification (Q38802991) (← links)
• Clinical translation of MS-based, quantitative plasma proteomics: status, challenges, requirements, and potential (Q39657160) (← links)
• Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis. (Q40975840) (← links)
• Assessment of the Therapeutic Potential of Persimmon Leaf Extract on Prediabetic Subjects (Q41288575) (← links)
• Evaluation of Multi-tRNA Synthetase Complex by Multiple Reaction Monitoring Mass Spectrometry Coupled with Size Exclusion Chromatography (Q42613865) (← links)
• Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel (Q47154567) (← links)
• Highly Sensitive Detection of Protein Biomarkers with Organic Electrochemical Transistors (Q47689680) (← links)
• Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer (Q48113573) (← links)
• Development of a Multiplexed Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry (LC-MRM/MS) Method for Evaluation of Salivary Proteins as Oral Cancer Biomarkers (Q48196134) (← links)
• Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS). (Q48368428) (← links)
• A standardized kit for automated quantitative assessment of candidate protein biomarkers in human plasma. (Q53182929) (← links)
• The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation. (Q54766883) (← links)
• Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target (Q58702505) (← links)
• Tailored Use of Targeted Proteomics in Plant-Specific Applications (Q58769528) (← links)
• A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic (Q92170611) (← links)
• Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic cancer (Q100513909) (← links)